Hungary eyes 30% cut to pharma budget

Hungary's economic reform program, which will be announced next month, could include cuts of about 30 percent to the national drug reimbursement bill, the government has said. Report

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.